Karachi, 27th July 2013: Hepatitis has emerged as a major global health problem and needs urgent prevention and control. Hepatitis B and C can be transmitted through the use of infected blood, the use of contaminated syringes during medical procedures or injection drug use. Diagnosing the disease at early stage and proper treatment reduces the disease by 90%. These views were expressed by experts at a Public Awareness Seminar organized by Dow University of Health Sciences (DUHS) to mark the World Hepatitis Day 2013.
National Institute of Liver & G.I. Diseases, Dow University of Health Sciences (DUHS) to celebrate World Hepatitis Day organized a Hepatitis Walk and Public Awareness Seminar at its Ojha Campus along with Hepatitis Free Testing and Screening Camp. The Walk started from National Institute of Liver & G.I. Diseases (NILGID) and ended up at OPD Block. In the walk, participants were carrying placards and chanting slogan against Hepatitis.
Dr. Rana Qamar Masood, Director-NILGID speaking on the occasion said that Hepatitis is spreading very fast. It is very important to screen the blood properly for these viruses and observe proper sterilization measures during dental and surgical procedures. Awareness is very important for the prevention of Hepatitis. It is a disease which has no complication therefore diagnosing the disease at early stage and proper treatment reduces the disease by 90%. He stressed on to avoid unnecessary injections and create an awareness campaign regarding this deadliest disease.
Briefing about the Hepatitis treatment facility at DUHS, she informed that considering the lack of facilities, complications and costly treatment of liver diseases, Dow University has established a National Institute of Liver & G.I. Diseases at its Ojha Campus which is one of its type, where all the Indoor and outdoor treatment facilities including Intensive Care treatment and Endoscopy will also be provided, besides other facilities, at bare minimum cost. Pakistan’s first Fibroscan Machine of Pakistan has been installed at National Institute of Liver & GI Diseases, DUHS. This machine would obviate the need of liver biopsy in patients suffering from HBV & HCV and would save cost of liver biopsy without the risks involved in liver biopsy.
Others who spoke on the occasion includes, Dr. Zahid Azam, Associate Professor, NILGID, DUHS, Dr. Sabihta Shaikh, Assistant Professor, NILGID, DUHS, Dr. Tayyab Usmani, Assistant Professor, NILGID, DUHS.